BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38481380)

  • 1. Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database.
    Luo C; Fan L; Lun W; Ma M; Liang L; Yu C
    J Chemother; 2024 Apr; 36(2):167-178. PubMed ID: 38481380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whether early stage pancreatic ductal adenocarcinoma patients could benefit from the post-operation chemotherapy regimens: a SEER-based propensity score matching study.
    Shi J; Li X; Wu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):375-382. PubMed ID: 34402250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset pancreatic cancer: a population-based study using the SEER registry.
    Ansari D; Althini C; Ohlsson H; Andersson R
    Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database.
    Hu H; Xu Y; Zhang Q; Gao Y; Wu Z
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):467-476. PubMed ID: 38656796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.
    He C; Zhang Y; Cai Z; Lin X
    BMC Cancer; 2019 May; 19(1):509. PubMed ID: 31142278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database.
    Wang Y; Zhou Y; Chen Y; Xia R; Liu J
    Technol Cancer Res Treat; 2022; 21():15330338221106533. PubMed ID: 35770310
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
    Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W
    Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
    Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
    Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
    Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
    Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis.
    Li Y; Liu W; Zhao L; Xu Y; Yan T; Yang Q; Pei Q; Güngör C
    Med Sci Monit; 2020 May; 26():e921515. PubMed ID: 32358953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
    Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
    Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis prediction and comparison between pancreatic signet ring cell carcinoma and pancreatic duct adenocarcinoma: a retrospective observational study.
    Zhou H; Li XX; Huang YP; Wang YX; Zou H; Xiong L; Liu ZT; Wen Y; Zhang ZJ
    Front Endocrinol (Lausanne); 2023; 14():1205594. PubMed ID: 37534212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
    Chen X; Liu G; Wang K; Chen G; Sun J
    Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases.
    Wu L; Lu Y; Chen L; Yue X; Cen C; Zheng C; Han P
    Curr Oncol; 2022 Oct; 29(10):7912-7924. PubMed ID: 36290902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database.
    Fang Y; Pu N; Zhang L; Wu W; Lou W
    Ann Transl Med; 2019 Oct; 7(20):522. PubMed ID: 31807504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study.
    Zhang Y; Xu G; Chen M; Wei Q; Zhou T; Chen Z; Shen M; Wang P
    Front Oncol; 2020; 10():1018. PubMed ID: 32766130
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries.
    Hu X; Hu D; Fu B; Li H; Ren G; Liu H; Song J; Kang X; Wang X; Pang H; Liu C; Zhang J; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1225979. PubMed ID: 38027134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.